Alignment-independent technique for 3D QSAR analysis.

Area of Science:

• Computational chemistry
• Molecular modeling
• Medicinal chemistry

Background:

• 3D molecular conformations are crucial for biochemical activity but computationally intensive for large datasets.
• Existing structure-activity relationship (SAR) models often avoid 3D descriptors due to computational overhead.
• Investigating efficient methods for defining molecular conformations is key for developing scalable SAR models.

Purpose of the Study:

• To evaluate how different methods of defining molecular conformations impact 3D-quantitative structure-activity relationship (QSAR) models.
• To compare the performance and computational efficiency of various conformation strategies.
• To determine if simpler, faster methods can yield accurate predictive models for nuclear receptor binders.

Main Methods:

• A dataset of 146 androgen receptor binders was used.
• Four conformation strategies were tested: global minimum energy, template alignment (equal/best-fit contributions), and non-optimized 2D > 3D.
• Models were built using these conformations, and their predictive performance (R Test (2)) was compared.

Main Results:

• The best performing model used 2D > 3D descriptors (R Test (2) = 0.61), outperforming energy-minimized and aligned conformations.
• The 2D > 3D method required only 3-7% of the computational time of other strategies.
• Consensus predictions from models using different conformations achieved a higher R Test (2) of 0.65.
• Analysis of the best 2D > 3D model identified 10 substructural features contributing to androgen receptor binding.

Conclusions:

• Non-energy optimized, 2D > 3D descriptors provide a computationally efficient and accurate alternative for 3D-QSAR modeling.
• This approach is particularly promising for large datasets involving relatively inflexible molecules, such as endocrine system nuclear receptors.
• The findings suggest a paradigm shift towards simpler descriptors for scalable predictive modeling in drug discovery.